ArticleBiomedicines2024

Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan.

Masashi Omori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.